+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Thrombosis Drugs Market 2024-2028 - Product Thumbnail Image

Thrombosis Drugs Market 2024-2028

  • Report
  • August 2024
  • 144 Pages
  • Global
From
Orphan Drugs Market Report 2023-2033 - Product Thumbnail Image

Orphan Drugs Market Report 2023-2033

  • Report
  • October 2023
  • 258 Pages
  • Global
From
Sickle Cell Disease Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Sickle Cell Disease Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
Therapeutic Injectable Drugs - Devices, Products and Markets - Product Thumbnail Image

Therapeutic Injectable Drugs - Devices, Products and Markets

  • Report
  • June 2023
  • 235 Pages
  • Global
From
From
Drug Repurposing Market - Global Strategic Business Report - Product Thumbnail Image

Drug Repurposing Market - Global Strategic Business Report

  • Report
  • March 2026
  • 377 Pages
  • Global
From
Sickle Cell Treatment Market - Global Forecast to 2030 - Product Thumbnail Image

Sickle Cell Treatment Market - Global Forecast to 2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
From
Precision Medicine - Global Strategic Business Report - Product Thumbnail Image

Precision Medicine - Global Strategic Business Report

  • Report
  • March 2026
  • 279 Pages
  • Global
From
Recombinant DNA Technology - Global Strategic Business Report - Product Thumbnail Image

Recombinant DNA Technology - Global Strategic Business Report

  • Report
  • March 2026
  • 212 Pages
  • Global
From
From
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • March 2026
  • 211 Pages
  • Global
From
Antineoplastic Agents - Global Strategic Business Report - Product Thumbnail Image

Antineoplastic Agents - Global Strategic Business Report

  • Report
  • March 2026
  • 183 Pages
  • Global
From
Interferons Market 2025-2029 - Product Thumbnail Image

Interferons Market 2025-2029

  • Report
  • May 2025
  • 212 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2026 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Company Snapshots: US Biotechnology - Product Thumbnail Image

Company Snapshots: US Biotechnology

  • Newsletter
  • March 2026
  • 35 Pages
  • United States
From
Loading Indicator